Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril for Painful Venous Malformations
2023-510076-31-00Phase 2Authorised
- Sponsor
- Oslo University Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enalapril in venous malformation (VM), sponsored by Oslo University Hospital. Primary endpoint: Change in pain intensity (NRS). Planned start Jun 2024; status: authorised.
02
Drugs
enalapril
03
Conditions
venous malformation (VM)
Beyond the preview
Go deeper on 2023-510076-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510076-31-00.